Penumbra
PEN
#1750
Rank
NZ$19.69 B
Marketcap
NZ$502.96
Share price
-1.39%
Change (1 day)
21.93%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Earnings for Penumbra (PEN)

Earnings in 2025 (TTM): NZ$0.32 Billion

According to Penumbra's latest financial reports the company's current earnings are NZ$1.33 Billion. In 2024 the company made an earning of NZ$38.55 Million a decrease over its 2023 earnings that were of NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Penumbra from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.32 B737.39%
2024 NZ$38.55 M-66.43%
2023 NZ$0.11 B991.52%
2022 NZ$10.52 M-181.08%
2021 -NZ$12.98 Million-80.74%
2020 -NZ$67.37 Million-181.97%
2019 NZ$82.18 M58.45%
2018 NZ$51.87 M2473.65%
2017 NZ$2.01 M-186.3%
2016 -NZ$2.34 Million-132.3%
2015 NZ$7.22 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Inari Medical
NARI
-NZ$91.79 Million-128.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merit Medical
MMSI
NZ$0.31 B-3.23%๐Ÿ‡บ๐Ÿ‡ธ USA